NCT02985450 A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada Status COMPLETED Phase N/A
NCT02982837 To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis B Status UNKNOWN Phase PHASE4
NCT02981602 Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection Status COMPLETED Phase PHASE2
NCT02959684 Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in France Status UNKNOWN Phase N/A
NCT02909023 Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or Cured Status COMPLETED Phase N/A
NCT02858440 A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia Status COMPLETED Phase PHASE3
NCT02853929 Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery Status COMPLETED Phase PHASE4
NCT02849132 Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT02826018 A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection Status TERMINATED Phase PHASE1
NCT02817451 DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants Status COMPLETED Phase PHASE3
NCT02799316 Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies? Status UNKNOWN Phase NA
NCT02798952 A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy Status COMPLETED Phase PHASE4
NCT02797522 A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB) Status TERMINATED Phase PHASE1
NCT02791386 Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy Status COMPLETED Phase N/A
NCT02779465 Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase PHASE4
NCT02766933 Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study Status COMPLETED Phase N/A